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intervention is impossible. Chemotherapy has shown no ben-
eficial outcome unless malignancy is present. The overall
prognosis for IPT is excellent. Most recurrences will arise
during the first year after initial therapy. Only a few reports
showed late-onset recurrences.
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Brief CommunicationsInfective mitral valve myxoma with coronary artery embolization:
Surgical intervention followed by prolonged survival
Feng Yao, MD, Zhi-yun Xu, MD, Yan-lin Liu, MS, and Lin Han, MD, Shanghai, People’s Republic of ChinaThree-quarters of primary cardiac neoplasms are benign;
nearly half of benign heart tumors are myxomas, which
have an estimated incidence of 0.5 per million population
per year.1,2 Roughly 75% of myxomas originate from the
left atrium, and 15% to 20% originate from the right atrium.
Myxomas of the heart valves are exceedingly rare.1 Myxo-
mas may simulate infective endocarditis, but rarely are
they actually infected.
We report a case of a 12-year-old child with an infective
myxoma originating from the ventricular side of the anterior
mitral leaflet with a coronary artery embolism.
CLINICAL SUMMARY
A 12-year-old girl from a rural area of mainland China
with a 9-year history of recurrent intermittent fevers and
night sweats was admitted to our hospital on April 4,
2001. During the 9 years prior to admission, the girl was di-
agnosed with an upper respiratory tract infection each time
she developed high fever. This diagnosis was given because
no other positive evidence could be found, and the girl was
treated with empirical antibiotics. At the time of admission,
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(39.5C) for 3 weeks. These fevers were unresponsive to
high doses of intravenous penicillin. Moreover, the patient
had developed severe dyspnea and lower extremity edema.
There was a III/6 soft, blowing, systolic murmur at the
apex on auscultation.
Neisseria lactamicawas isolated from blood cultures on 2
consecutive days, and an emergency echocardiogram was
obtained, which revealed a mass in the left ventricle attached
to the anterior mitral leaflet, with severe mitral regurgitation
(Figure 1).
FIGURE1. Transthoracic echocardiography in the 4-chamber apical view,
revealing a left ventricular mass (arrow) attached to the anterior mitral leaf-
let. LV, left ventricle; RV, right ventricle; LA, left atrium; RA, right atrium.Cardiovascular Surgery c Volume 137, Number 3 749
FIGURE 2. A, Pathologic specimen of the removed mitral valve covered by the myxoma and part of the papillary muscle. B, The majority part of the spec-
imen exhibits typical characteristics of myxoma (ie, eristic acid–mucopolysaccharide matrix) and embedded polygonal cells (hematoxylin and eosin staining,
magnification3200). C, Acid–mucopolysaccharide matrix (periodic acid Schiff staining, magnification3200). D, The minority part of the specimen shows
acute inflammation and extensive necrosis (hematoxylin and eosin, magnification 3200).
Brief CommunicationsCardiac surgery with cardiopulmonary bypass was per-
formed 1 week later. A 3.5 3 2.5–cm grapelike tumor orig-
inating from the ventricular side of the anterior mitral leaflet
and papillary muscles was resected (Figure 2), and the mitral
valve was replaced with a 27-mm St Jude Medical mechan-
ical prosthetic valve (St Jude Medical, Inc, St Paul, Minn).
However, the patient could not be weaned from cardiopul-
monary bypass due to poor cardiac contractility. A coronary
artery examination showed that the left anterior descending
(LAD) branch of the coronary artery had been completely
occluded by a tumor fragment when it was incised. Emer-
gency coronary artery bypass grafting surgery was per-
formed using a saphenous vein as a grafting vessel and the
LAD as the target vessel. After this procedure, the patient
displayed satisfactory cardiac output and was weaned from
cardiopulmonary bypass uneventfully.
Microscopic pathology was consistent with a typical
myxoma but also demonstrated acute inflammation (Fig-
ure 2). However, Gram staining and tissue cultures were
negative. Postoperatively, the patient received 4 weeks of in-
travenous ceftriaxone therapy. After discharge, an echocar-
diogram was performed annually. The latest follow-up
echocardiogram, performed in August 2007, did not show
recurrent myxoma.
DISCUSSION
Although myxomas are rare in the cardiac surgical popu-
lation, they are the most common benign neoplasms of the
heart and represent the vast majority of all primary cardiac750 The Journal of Thoracic and Cardiovascular Sutumors.3 Cardiac myxomas may simulate infective endocar-
ditis, although they are rarely actually infected.4 The risk of
true infection still exists, however, because a myxoma pres-
ents a perfect infection site. A three-level definition of
infected cardiac myxomas has been proposed.5 Classifica-
tions include definite, probable, and possible infections and
are based on clinical and pathologic evidence. Criteria for
‘‘definite’’ infected myxomas include documented myxoma
by pathology accompanied by either positive blood cultures
and inflammation or microorganisms seen on pathology. In
our case, the documented myxoma as evidenced by clinical
examination, pathology, and positive blood cultures qualify
this case as a ‘‘definite’’ infected cardiac myxoma.
Systemic embolization occurs in 30% to 40% of patients
with myxomas, although the incidence of coronary emboli-
zation in patients with myxomas is only 0.06%.5 Although
special care was taken in our case to avoid embolization of
cardiac myxoma fragments perioperatively, embolization
did occur during surgery procedures before crossclamping.
The following two factors may account for this. First, mitral
valve myxomas present a major risk of embolization because
of both the high mobility of their implantation areas and the
high pressure inside the left ventricle. Second, infected car-
diac myxomas are more dangerous than noninfected myxo-
mas: their incidence of embolization is increased two- to
threefold.5
We conclude that infective mitral valve myxoma is an ex-
tremely rare condition. Because it has such a high incidence
of embolization, emergency surgery should be done torgery c March 2009
Brief Communicationsremove this type of myxoma once it is diagnosed. During
surgical procedures, careful measures should be taken to
prevent fragments of the tumor from breaking away.
References
1. Reynen K. Cardiac myxomas. New Engl J Med. 1996;333:1610-7.The Journal of Thoracic and2. MacGowan SW, Sidhu P, Aherne T, et al. Atrial myxoma: national incidence,
diagnosis and surgical management. Ir J Med Sci. 1993;162:223-6.
3. Roschkov S, Rebeyka D, Mah J, et al. The dangers of cardiac myxomas. Prog
Cardiovasc Nurs. 2007;22:27-30.
4. Vogt PR, Jenni R, Turina MI. Infected left atrial myxoma with concomitant mitral
valve endocarditis. Eur J Cardiothorac Surg. 1996;10:71-3.
5. Revankar SG, Clark RA. Infected cardiac myxoma: case report and literature
review. Medicine. 1998;77:337-44.Familial fetal-type rhabdomyoma of the tricuspid valve in the
neonate: Malignant course for a benign disease
Francesca Viscardi, MD,a Gabriella Errico, MD,b Nicola Schiavo, MD,c Paolo Biban, MD,b Alessandro Mazzucco, MD,a and
Giovanni Battista Luciani, MD,a Verona, ItalyWe report 2 brothers with prenatal diagnosis of tricuspid
valve masses, both requiring aggressive intensive care resus-
citation shortly after birth and surgical excision of the tumor,
which proved to be a fetal-type rhabdomyoma. The unique
pathologic and clinical features of this rare disease are
discussed.
CLINICAL SUMMARY
Patient 1. The first child had a critical neonatal period due
to severe tricuspid valve stenosis, caused by 3 obstructive
cardiac masses and severe pulmonary hypertension. Treat-
ment included balloon atrial septostomy to maintain cardiac
output and mechanical ventilation, with prostaglandin E1
(PGE1) infusion and inhaled nitric oxide (NO) for 2 months
after birth. Discharge therapy with sildenafil and bosentan
was continued until the time of elective surgical resection
of tricuspid valve masses (Figure 1, A), at 11 months of
age. Histology showed only dystrophic calcification. Excel-
lent tricuspid valve function and no recurrence of cardiac
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year after operation. The child has no clinical nor laboratory
evidence of tuberous sclerosis.
Patient 2. The younger brother also had severe tricuspid
valve obstruction (functional atresia), due to a huge tricuspid
valve mass, and pulmonary hypertension at birth, with echo-
cardiographic evidence of adequate right-to-left shunting at
the atrial septal level. Mechanical ventilation, PGE1 infu-
sion, and inhaled NO failed to stabilize clinical status, and
emergency surgical resection was required at 21 days of
life (Figure 1, B). Despite satisfactory repair of tricuspid
valve, extracorporeal membrane oxygenation (ECMO) sup-
port was necessary for refractory hypoxia. Six days after
ECMO weaning, the neonate died due to sepsis and recur-
rent respiratory failure. Histology of the lesion evidenced
fibromyxoid stroma and isolated spindle cells with eosino-
philic cytoplasm (Figure 2, A); immunohistochemical stain-
ing was positive for desmin (Figure 2, B). The final
pathologic diagnosis was calcified fetal rhabdomyoma of
the tricuspid valve and recurrent pulmonary embolism,
with no evidence of tuberous sclerosis.
DISCUSSION
The clinical and pathologic features of the 2 sibling pa-
tients herein are very uncommon. Considering the frequency
of rhabdomyoma as cause of fetal and neonatal primary car-
diac tumor,1 findings of large, hyperechogenic intracardiac
masses suggested rhabdomyoma as presumptive diagnosis
in both patients. On the contrary, tricuspid valve location,
absence of tuberous sclerosis,1,2 no tendency toward regres-
sion, severe intracardiac obstruction with repeated pulmo-
nary embolization, and, most unusually, familial recurrence
brought the latter diagnosis into question. AlthoughCardiovascular Surgery c Volume 137, Number 3 751
